Home Blog Page 3
ConAgra insider Craig Omtvedt bought $1.35 million of the food giants's stock two weeks after ConAgra Brands Inc (CAG) reported surprisingly good earnings and upped its guidance. CAG hit 52-week highs after the report. Omtvedt's Form 4 disclosing his purchase came after market hours on Jan. 3. Omtvedt has been a director of...
On Dec. 23, Nierenberg Investment filed a 13D/A on Houston Wire and Cable (HWCC). The investment adviser expressed frustration that the market value of its long-held position in the micro-cap has "widened substantially over the last two years." The filing amended a 13D from Dec.17 of 2018 in which the investment adviser disclosed...
The decade's top 20 hedge funds did something remarkable: They handily outperformed the S&P 500 -- a difficult accomplishment during the relentless bull market. The S&P 500 total return index has averaged about a 13.5% annual return over the last decade. But the average fund on the top 20 hedge fund list returned...
Myriad Genetics co-founder Walter Gilbert PhD bought $150K of MYGN on Dec. 13 @ $25.60. Gilbert, who won the Nobel Prize for Chemistry in 1980, has a history of Form 4 filings at Myriad dating back to 2006. However, this is the insider's first open market purchase of MYGN shares. Gilbert received a...
Engine Capital filed a 13D on Cymabay (CBAY) two weeks after the development stage biotech company halted a trial of its leading drug candidate causing it's shares to fall as much as 75%. In a 13D filing Thursday evening, New York-based Engine Capital, L.P. disclosed a 7.3% stake in CBAY. The hedge fund reported...
Perceptive Advisors' Neptune Wellness Solutions (NEPT) position increased by 50% during the 3rd quarter of 2019, to 4.5 million shares. The stake represents 14.53% of the Cannabis extraction company's outstanding shares. NEPT was Perceptive Advisors' #20 position at Q3 close. The increase in Perceptive' Advisors' Neptune Wellness stake came amidst a terrible 2019 for...
Protagonist Therapeutics insiders bought on Tuesday as their company's stock plummeted after preliminary data appeared to cast doubt on Protagonist's (PGTX) key drug. On Monday, the company presented an initial look at preliminary results from the TRANSCEND Ph2 open-label study of PTG-300 (hepcidin mimetic) focusing on patients with transfusion-dependent (TD) beta-thalassemia (beta-thal). The...
Is Bill Oberndorf the best stock picker in the U.S.? According to a recent report by WhaleWisdom.com, two professional fund managers shared the top ranking for risk-adjusted performance of their stock picks. One of the top ranked funds was Abdiel Capital Advisers, L.P. with a WhaleScore ranking of 99. You may know of...
The January Effect and insider trading anomaly can combine for unusually profitable opportunities. As year-end approaches, it's a great time to scan the universe of equities for oversold, cheap stocks being accumulated by insiders. The January Effect refers to the tendency for stock prices -- especially small cap stocks -- to appreciate more in January than...
Stadium Capital's Q3 return of 33.01% was best among all hedge funds in the WhaleWisdom universe*. Tiger Legatus ranked #2 with a 31.81% return for the third quarter. *Performance was measured based on a "manager weighted" portfolio of all hedge funds' top 10 holdings at Q3's end, as reported in 13F filings disclosed last...